Edition:
United States

Diffusion Pharmaceuticals Inc (DFFN.OQ)

DFFN.OQ on NASDAQ Stock Exchange Capital Market

0.42USD
21 Sep 2018
Change (% chg)

$-0.03 (-5.78%)
Prev Close
$0.45
Open
$0.46
Day's High
$0.46
Day's Low
$0.42
Volume
65,381
Avg. Vol
34,878
52-wk High
$2.97
52-wk Low
$0.31

Chart for

About

Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC)... (more)

Overall

Beta: -1.90
Market Cap(Mil.): $21.98
Shares Outstanding(Mil.): 50.57
Dividend: --
Yield (%): --

Financials

  DFFN.OQ Industry Sector
P/E (TTM): -- 108.45 32.71
EPS (TTM): -0.11 -- --
ROI: -1.74 1.54 12.72
ROE: -77.92 0.30 14.84

Earnings vs. Estimates